Median Tmax? [Regulatives / Guidelines]

posted by ratnakar1811 – India, 2008-04-04 07:35 (6286 d 18:26 ago) – Posting: # 1760
Views: 38,454

(edited on 2008-04-04 09:48)

Dear HS,

Thanks for your prompt reply, but the question remained unanswered that when we should exclude the subject from the study, is after bioanalysis or at the time of clinical phase only and if at the clininal phase what should be used as a basis for the same?

And as you have suggested considering the partial area, how it should be done practically?

Best Regards,

Ratnakar
--
Edit: Full quote removed. Please see this post! [Ohlbe]

Complete thread:

UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,672 registered users;
38 visitors (0 registered, 38 guests [including 7 identified bots]).
Forum time: 02:01 CEST (Europe/Vienna)

Medical researches can be divided into two sorts:
those who think that meta is better and those
who believe that pooling is fooling.    Stephen Senn

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5